| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.82M | - | |
| Dir | 22.0K | $1.19M | - | |
| CFO | 19.5K | $1.05M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $919.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 18,568 | $54.21 | $1,006,580.40 | -4.6% | -26.0% | +3.1% | |
| Feb 19, 2025 | Kasinger James R.61 | General Counsel And Secretary | Sale+OE | 11,542 | $53.67 | $619,492.35 | -7.2% | -26.0% | +3.1% | |
| Dec 2, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sell | 15,000 | $55.10 | $826,564.50 | -7.6% | -23.3% | -6.5% | |
| Nov 11, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sell | 30,000 | $55.62 | $1,668,678.36 | -7.0% | -28.2% | +0.6% | |
| Oct 14, 2024 | Kasinger James R.61 | General Counsel And Secretary | Sale+OE | 1,089 | $46.28 | $50,398.92 | -1.7% | -18.8% | +45.1% | |
| Oct 14, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 4,293 | $46.28 | $198,680.04 | -1.9% | -18.8% | +45.1% | |
| Jun 21, 2024 | Bruno Julianne48 | Chief Operating Officer | Sale+OE | 3,366 | $56.09 | $188,798.94 | -33.3% | -12.0% | -21.3% | |
| Apr 15, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 19,582 | $59.91 | $1,173,231.52 | -4.5% | -2.1% | -33.7% | |
| Mar 15, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 20,000 | $72.48 | $1,449,628.16 | -4.5% | -10.5% | -42.3% | |
| Mar 15, 2024 | Prasad Raju53 | Chief Financial Officer | Sale+OE | 3,524 | $72.69 | $256,159.56 | -35.2% | -10.5% | -42.3% |